BIOCON TIME FRAME : WEEKLY CHART PATTERN : DOUBLE BOTTOM
About Biocon Ltd. The company is an innovation-led global biopharmaceuticals company committed to enhance affordable access to complex therapies for chronic conditions like diabetes, cancer and autoimmune. It has developed and commercialized novel biologics, biosimilars, and complex small molecule APIs in India and several key global markets as well as generic formulations in the US and Europe. It also has a pipeline of promising novel assets in immunotherapy under development.
Sector Healthcare Sector Industry Pharmaceuticals & Drugs Market Cap 34,865.42 Cr.
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.